Indications and Usage for Victoza®
Victoza® (liraglutide [rDNA origin] injection) is an injectable prescription medicine
that may improve blood sugar (glucose) in adults with type 2 diabetes when used
along with diet and exercise.
Victoza® is not recommended as the first medication to treat diabetes. Victoza®
has not been studied in patients with history of inflammation of the pancreas (pancreatitis).
Victoza® is not a substitute for insulin and has not been studied in combination
with prandial (mealtime) insulin. Victoza® is not for people with type 1 diabetes
or people with diabetic ketoacidosis. It is not known if Victoza® is safe and effective
in children. Victoza® is not recommended for use in children.
Important Safety Information for Victoza®
In animal studies, Victoza® caused thyroid tumors—including thyroid cancer—in
some rats and mice. It is not known whether Victoza® causes thyroid tumors or a
type of thyroid cancer called medullary thyroid cancer (MTC) in people, which may
be fatal if not detected and treated early. Do not use Victoza® if you or any of
your family members have a history of MTC or if you have Multiple Endocrine Neoplasia
syndrome type 2 (MEN 2). While taking Victoza®, tell your doctor if you get a lump
or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.
These may be symptoms of thyroid cancer.
Do not use Victoza® if you are allergic to liraglutide or any of the ingredients
in Victoza®. Serious allergic reactions can happen with Victoza®. If symptoms of
serious allergic reactions occur, stop taking Victoza® and seek medical attention.
Pancreatitis may be severe and lead to death. Before taking Victoza®, tell your
doctor if you have had pancreatitis, gallstones, a history of alcoholism, or high
blood triglyceride levels since these medical conditions make you more likely to
Stop taking Victoza® and call your doctor right away if you have pain in your stomach
area that is severe and will not go away, occurs with or without vomiting, or is
felt going from your stomach area through to your back. These may be symptoms of
Before using Victoza®, tell your doctor about all the medicines you take, especially
sulfonylurea medicines or insulin, as taking them with Victoza® may affect how each
medicine works. If you use Victoza® with insulin, you may give both injections in
the same body area (for example, your stomach area), but not right next to each
Also tell your doctor if you have severe stomach problems such as slowed emptying
of your stomach (gastroparesis) or problems with digesting food; have or have had
kidney or liver problems; have any other medical conditions; or are pregnant or
plan to become pregnant. Tell your doctor if you are breastfeeding or plan to breastfeed.
It is unknown if Victoza® will harm your unborn baby or if Victoza® passes into
your breast milk.
Your risk for getting hypoglycemia, or low blood sugar, is higher if you take Victoza®
with another medicine that can cause low blood sugar, such as a sulfonylurea or
insulin. The dose of your sulfonylurea medicine or insulin may need to be lowered
while taking Victoza®.
Victoza® may cause nausea, vomiting, or diarrhea leading to dehydration, which may
cause kidney failure. This can happen in people who have never had kidney problems
before. Drinking plenty of fluids may reduce your chance of dehydration.
The most common side effects with Victoza® include headache, nausea, and diarrhea.
Nausea is most common when first starting Victoza®, but decreases over time in most
people. Immune system related reactions, including hives, were more common in people
treated with Victoza® compared to people treated with other diabetes drugs in medical
click here for Victoza® Prescribing Information.
Victoza® is a prescription medicine.
Indications and Usage for NovoLog® Mix 70/30
What is NovoLog® Mix 70/30 (70% insulin aspart protamine suspension
and 30% insulin aspart injection, [rDNA origin])?
- NovoLog® Mix 70/30 is a man-made insulin used to control high blood
sugar in adults with diabetes mellitus.
- It is not known if NovoLog® Mix 70/30 is safe or effective in children.
Important Safety Information for NovoLog® Mix 70/30
Who should not use NovoLog® Mix 70/30?
- Do not use NovoLog® Mix 70/30 if your blood sugar is too low (hypoglycemia)
or you are allergic to any of its ingredients.
What should I tell my health care provider before taking NovoLog®
- About all of your medical conditions, including liver, kidney, or heart problems.
- If you are pregnant, breastfeeding, or plan to do either.
- About all prescription and nonprescription medicines you take, including supplements,
as your dose may need to change.
How should I take NovoLog® Mix 70/30?
- NovoLog® Mix 70/30 starts acting fast. If you have type 1 diabetes,
inject within 15 minutes before you eat a meal. If you have type 2 diabetes, inject
within 15 minutes before or after starting your meal.
- Inject NovoLog® Mix 70/30 under the skin of your stomach area, upper
arms, buttocks, or thighs, but never into a vein or muscle.
- Do not mix NovoLog® Mix 70/30 with other insulin products or use
in an insulin pump.
- Do not change your dose or type of insulin unless you are told to by your health
- Do not share needles, insulin pens, or syringes.
- Check your blood sugar levels as directed by your health care provider.
What should I consider while using NovoLog® Mix 70/30?
- Alcohol, including beer and wine, may affect your blood sugar.
- Be careful when driving a car or operating machinery. You may have difficulty concentrating
or reacting if you have low blood sugar. Talk to your health care provider if you
often have low blood sugar or no warning signs of low blood sugar.
What are the possible side effects of NovoLog® Mix 70/30?
- Low blood sugar, including when too much is taken. Some symptoms include sweating,
shakiness, confusion, and headache. Severe low blood sugar can cause unconsciousness,
seizures, and death.
- Serious allergic reactions may occur. Get medical help right away, if you develop
a rash over your whole body, have trouble breathing, a fast heartbeat, or sweating.
- Other side effects include low potassium in your blood, injection site reactions
(like redness, swelling, and itching), skin thickening or pits at the injection
site, weight gain, swelling of your hands and feet, if taken with thiazolidinediones
(TZDs) possible heart failure, and vision changes.
Please click here
for NovoLog® Mix 70/30 Prescribing Information.
NovoLog® Mix 70/30 is a prescription medicine.
Talk to your doctor about the importance of diet and exercise in your treatment plan.
You are encouraged to report negative side effects of prescription drugs to the
www.fda.gov/medwatch, or call 1-800-FDA-1088.
If you need assistance with prescription drug costs, help may be available. Visit
or call 1-888-4PPA-NOW.
Levemir®, Novolin®, NovoLog®, and Victoza® are registered trademarks of Novo Nordisk
A/S. Bydureon® and Byetta® are registered trademarks of the AstraZeneca group of
companies. Humalog® and Humulin® are registered trademarks of Eli Lilly and Company.
Apidra® and Lantus® are registered trademarks of sanofi-aventis U.S. LLC.
This website is intended for use by United States residents only. The content is
for informational purposes only and is not intended to replace a discussion with
a health care provider.